James F. Taulman, Founder – Former Editor-in-Chief of the first independently licensed website to offer stock reports and services based on the CAN SLIM® investment system.
1) VIPS – Previously featured. Made some solid gains by mid-week of +7%. Pulled back to its 50-day on Friday. Would be looking to add more Monday and continue to build a position as long as the 50 DMA near $14 is held.
2) JD – Somewhat of a sister stock to VIPS. Has continuously found support at its 50 DMA as well. Looking to start building a position along the same guidelines as VIPS (above), this one just above $40.
3) QDEL – Our latest BreakOut Alert (+14.7%) at BuyingBreakOuts.com. Has been profitable, yet volitile. Holding its 10-day line. Looks ready to again move higher. Any early bullish action looks tradeable up to at least the previous highs near $103.
4) BMY – Aggressively getting back above its 200 DMA. Looking for it to hold above there, while eventually meeting its falling 50-day line, currently at $59.46.
5) IPHI – Fell to support of its previous lows near $56, then blasted back above its 200-day line. Recently cleared its 50-day and now may be setting up to breakout to new highs.
6) STN – New to my personal watch list. Successfully tested support of its previous lows near $21. Last 2 trading sessions show above average volume gains as shares re-take their 200-day moving average in a bullish fashion. RS line confirming.
7) RGEN – Found support at its 200 DMA, just cleared its 50-day line. Not much overhead supply in the way of potential new highs.
8) BIO – Held at $320 during market sell off, jumped above its 200-day, then just cleared its 50 DMA on Friday with solid volume conviction of +120%. Looks poised to move higher on Monday.
9) TYL – Pulled back to $250, during the market correction, shot up to hit its 50-day line, was defended back at its 200 DMA on Friday. Closed at the session highs. Volume was notable lighter on Friday advance. Stock needs to hold the 200-day, currently at $2758.44.
About the Site’s Founder
For more than 8 years James had served as Editor-in-Chief an independently licensed website that offered stock reports and services based on the CAN SLIM® investment system.
He has developed a knack for being able to quickly and accurately analyze high-ranked stocks based on this winning investment strategy.
Over the years, Mr. Taulman has enjoyed assisting individuals from professional money managers to private investors with their needs in relation to implementing this investment approach on a daily basis in the current marketplace.
Each Sunday you could hear him deliver his weekly market report as part of the “Your Money Matters” radio program on ABC and CBS radio networks.
Disclaimer: James Taulman nor buyingbreakouts.com is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The independent contractors and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company’s website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company’s products (collectively, the “Information”) are provided for informational and educational purposes only and should not be construed as investment advice.